Genetic polymorphism of Plasmodium falciparum circumsporozoite protein on Bioko Island, Equatorial Guinea and global comparative analysis

被引:0
作者
Hui-Ying Huang
Xue-Yan Liang
Li-Yun Lin
Jiang-Tao Chen
Carlos Salas Ehapo
Urbano Monsuy Eyi
Jian Li
Ting-Ting Jiang
Yu-Zhong Zheng
Guang-Cai Zha
Dong-De Xie
Jin-Quan He
Wei-Zhong Chen
Xiang-Zhi Liu
Huan-Tong Mo
Xin-Yao Chen
Min Lin
机构
[1] Hanshan Normal University,School of Food Engineering and Biotechnology
[2] Shantou University Medical College,Department of Medical Genetics
[3] Huizhou Central Hospital,Department of Medical Laboratory
[4] The Chinese Medical Aid Team to the Republic of Equatorial Guinea,Department of Medical Laboratory
[5] Malabo Regional Hospital,Department of Human Parasitology, School of Basic Medical Sciences, Department of Infectious Diseases, Renmin Hospital
[6] Hubei University of Medicine,Department of Medical Laboratory
[7] Chaozhou People’s Hospital Affiliated to Shantou University Medical College,undefined
来源
Malaria Journal | / 19卷
关键词
Malaria; Circumsporozoite protein; Genetic polymorphism; Bioko Island;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 247 条
[1]  
Mac-Daniel L(2019)Live vaccines against Methods Mol Biol 2013 189-198
[2]  
Menard R(2018) preerythrocytic stages Cell Host Microbe 24 43-56
[3]  
Draper SJ(2010)Malaria vaccines: recent advances and new horizons Vaccine. 28 4880-4894
[4]  
Sack BK(2012)The RTS, S malaria vaccine PLoS ONE. 7 e43430-2529
[5]  
King CR(2018)Genetic variation in the PLoS ONE 13 e0209744-318
[6]  
Nielsen CM(2014) circumsporozoite protein in India and its relevance to RTS, S malaria vaccine PLoS Med. 11 e1001685-403
[7]  
Rayner JC(2016)Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 malaria vaccine program in sub-Saharan Africa: a systematic review N Engl J Med 374 2519-26963
[8]  
Higgins MK(2018)Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites Am J Trop Med Hyg 98 308-630
[9]  
Casares S(1985)Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children Cell 42 401-2037
[10]  
Brumeanu TD(2009)Advancing global health through development and clinical trials partnerships: a randomized, placebo-controlled, double-blind assessment of safety, tolerability, and immunogenicity of PfSPZ vaccine for malaria in healthy Equatoguinean men J Biol Chem 284 26951-681